Friday, May 03, 2024

Events | 2019.02.01

I-Mab Biopharma and Bio-Cancer Treatment International Announce Intention for Collaboration on Arginine Depletion Therapy and Biomarker Study, with Plans for I-Mab to Establish a Translational Medicine Lab in Hong Kong

HONG KONG, Feb. 1, 2019 /PRNewswire/ -- I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune diseases, today announces that it has entered into a memorandum of...

 

For more information, please visit
https://www.prnewswire.com:443/news-rele[...]anslational-medicine-lab-in-ho

You need to login to post comments.

Feed last updated 2024/05/31 @11:05 PM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News